Synthesis of Stable Aluminum Nanoparticles at Varying Reactant Concentrations and Their Surface-Enhanced Raman Scattering Activity
Abstract
Aluminum nanoparticles (Al NPs) were synthesized via catalyzed thermal reduction of an aluminum precursor in the presence of a capping ligand. A systematic study was conducted to examine the effect of dilution on nanoparticle synthesis by varying the volume of anhydrous toluene across four dilution factors while maintaining constant molar quantities of the aluminum precursor, catalyst, and ligand. This methodology is relevant for scale-up processes, where more dilute conditions can mitigate nanoparticle reactivity and enhance safety. The resulting Al NPs were characterized with respect to the yield, size distribution, chemical composition (bulk and surface), and morphology. Consistent and favorable yields were observed across all of the dilution conditions. The synthesized Al NPs were further evaluated as low-cost substrates for surface-enhanced Raman spectroscopy (SERS). While Au and Ag nanoparticles are known to exhibit SERS activity in the visible region for chemical warfare agent (CWA) surrogates, little is known about SERS performance in the ultraviolet (UV) region by using metallic substrates. Al NPs, with broadband optical absorption extending from the UV to the near-infrared (NIR), were investigated for this application. Rhodamine 6G (R6G), a standard dye, and dimethyl methylphosphonate (DMMP), a commonly used CWA surrogate, were analyzed by using 248.6 nm UV excitation. The Al NPs exhibited modest SERS activity for both analytes under these conditions. To the best…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.